Ravi A. Madan, Clinical researcher at the National Cancer Institute, shared a post on X:
“Enthusiasm for the use of PSMA PET in Prostate Cancer exceeds our true understanding of the clinical implications.
This small sample of PSMA tumor volume data will be presented at ASCO GU 2026.
Unique in it is demonstrating data in responders.
It’s not quite what’s expected…”
Other OncoDaily articles featuring Ravi A. Madan.